Monday, June 15, 2026

The General’s Daughter Just Took Command: Plump Prince Makes Ju Ae The New Air Force Weapon

Kim Jong Un celebrated the Air Force's 80th anniversary, announcing plans for new military assets and missions to enhance capabilities.

Netflix Seires ‘Show Business’ Starring Song Hye Kyo, Gong Yoo Explores Music Industry

Netflix's upcoming drama "Show Business" features a star-studded cast, exploring the pursuit of stardom from the 1960s to 1980s.

North Korean Leader Emphasizes People-Centered Development in Rakwon Facility Tour

North Korea implements emergency measures to prevent flooding while Kim Jong Un inspects new fishing enterprise and promotes innovation.

Tag: loss

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Wegovy, Mounjaro Boom Creates New Winners as Ursa, InBody Ride GLP-1 Ripple Effects

GLP-1 obesity drugs are boosting gallstone prevention therapies and body composition monitoring, creating new market opportunities.

Samsung Launches GLP-1 Muscle Loss Study With Galaxy Watch8 and Harvard-Linked Hospital

Samsung is researching muscle loss management for GLP-1 drug users, led by the Galaxy Watch 8.

Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026

MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.

Significant Weight Loss Substantially Increases Mortality Risk in Dementia Patients

A study finds dementia patients with significant weight loss face higher mortality risks, while stable weight or moderate gain lowers risks.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

JW Pharmaceutical Secures Phase 1 Approval for Novel Hair Loss Treatment JW0061—What to Expect?

JW Pharmaceutical is investing in innovative hair loss treatments and expanding its drug portfolio, including successful cholesterol medications.

Will South Korea’s Health Insurance Cover Youth Hair Loss Treatments?

South Korea's Ministry of Health reviews youth hair loss treatment for insurance coverage, emphasizing public debate and cost-effectiveness.

Eli Lilly’s New Weight Loss Pill Foundayo: A Game Changer in the GLP-1 Market?

The FDA has approved Eli Lilly's oral obesity drug Foundayo, enhancing competition in the weight loss market with flexible dosing.

New Study Reveals Radiation Dose Reduction May Cause Tumor Recurrence in Meningioma Patients

A study reveals that lower radiation doses for benign meningiomas near the optic nerve may lead to worse long-term outcomes and tumor regrowth.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

GLP-1 Weight Loss Injections: Are They Causing Gallstone Surge in Asia?

GLP-1 obesity treatments are linked to increased gallstone risk, especially during rapid weight loss, with cases doubling in South Korea.

Unlocking Weight Loss: Hanmi Pharmaceutical’s Innovative H.O.P Project and the Game-Changing Epaglenatide

Hanmi Pharmaceutical is innovating obesity treatment with efpeglenatide and HM15275, focusing on tailored solutions for Korean patients.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.